Why the study?
To evaluate differences in PV-FARS10-AF CL between paroxysmal and persistent AF and determine an optimal cutoff to predict PVI-only success in a larger population.
Does a fastest pulmonary vein atrial fibrillation cycle length (PV-FARS10-AF CL) ≤155ms predict lower atrial arrhythmia recurrence in patients undergoing first PVI?
Does a fastest pulmonary vein atrial fibrillation cycle length (PV-FARS10-AF CL) ≤155ms predict lower atrial arrhythmia recurrence in patients undergoing first PVI?
A fastest pulmonary vein atrial fibrillation cycle length ≤155ms accurately identifies patients with paroxysmal or persistent AF who are more likely to remain free from arrhythmia recurrence after a PVI-only approach.
Background Atrial fibrillation cycle length (AF CL) measured in the pulmonary veins (PV) with a novel simple method (the average of the 10 consecutive Fastest Atrial Repetitive Similar signal interval [FARS10]) accurately identified pulmonary vein isolation (PVI) responders in a preliminary study. Aim To evaluate differences in PV-FARS10-AF CL between paroxysmal and persistent AF and to define the optimal cutoff to predict PVI-only approach success in a large population. Methods We prospectively enrolled consecutive patients with persistent or paroxysmal AF undergoing first PVI in a single center study. The primary endpoint was atrial arrhythmia recurrence. Results 219 patients (61.8 ± 11.2 years, 25.1% female) were included, with 70 patients (32%) having paroxysmal AF and 149 patients (68%) persistent AF. After a median follow-up of 18.0 (IQR 10.2 – 42.3) months, 72 (32.9%) patients experienced AF/AFL/AT recurrence. Patients with PV-FARS10-AF CL ≤155ms had a lower rate of AF/AFL/AT recurrence compared to those with PV-FARS10-AF CL >155ms in the overall population (HR 0.34, p < .001), in persistent AF (HR 0.40, p = .002) and in paroxysmal AF (HR 0.18, p = .01). In multivariable analysis – which included age, sex, BMI, CHA2DS2-VA score, obstructive sleep apnea syndrome (OSAS), duration of AF, AF type (paroxysmal vs. persistent), left ventricular ejection fraction (LVEF), left atrial volume index (LAVI), and AF termination during ablation – only the fastest PV-FARS10-AF CL ≤155ms was significant predictor of AF/AFL/AT recurrence free survival in the overall population (HR 0.45, CI: 0.26-0.78, p = .005). Paroxysmal AF patients more frequently had fastest PV-FARS10-AF CL ≤155ms than persistent AF patients (61.4% vs 42.3%, p = .009). Conclusion PV-FARS10-AF CL can accurately identify PVI-responders among patients with persistent and paroxysmal AF. Patients with slow PV-FARS10-AF CL (> 155ms) experience a higher rate of AF/AFL/AT recurrence after PVI only approach. The fastest PV-FARS10-AF CL ≤ 155ms occurs more frequently in paroxysmal AF patients than in persistent AF patients.
No takes yet. Share an insight, caveat, or question.
Marcon et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: